Latest News
Rigel's VEPPANU (vepdegestrant) available for patients with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer
14 August 2026 - Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a San Francisco-based commercial stage biotechnology company, announced on Thursday that VEPPANUTM (vepdegestrant) is now available by prescription in the United States for the treatment of...
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
14 August 2026 - Innorna, a Hong Kong-based clinical-stage biotech company advancing RNA medicines, announced on Thursday that it has been nominated for the 2026 Prix Galien USA Best Startup Award.Innorna was shortlisted in the Best Startup category,...
Elephas Biosciences partners Neuberg Diagnostics
14 August 2026 - Elephas Biosciences Corporation, a US-based private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced on Thursday an exclusive partnership with India-based Neuberg Diagnost...
Pilot Project between BioCytics and LIDE Biotech
14 August 2026 - BioCytics, Inc., a North Carolina-based biotechnology company, and LIDE Biotech, a China-based biotechnology company, announced on Thursday the formation of a strategic alliance to develop advanced screening platforms and companion d...
Pharming launches Joenja in Japan for APDS patients aged four and above
...